News for Xiamen Amoytop Biotech Co., Ltd. (688278.SS)

Amoytop to sponsor a Phase 1b exploratory clinical study evaluating the efficacy and safety of ALG-000184 in combination with PEGBING® (Mipeginterferon...

Aligos Therapeutics Enters Research Collaboration and Development Agreement with Xiamen Amoytop Biotech for Use of Aligos’ Oligonucleotide Platform

SOUTH SAN FRANCISCO, Calif., May 12, 2023 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver... | May 12, 2023

seattle, July 25, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global achondroplasia market is estimated to be valued at US$ 93.82...